BioTrove raises $7 million

Mar. 8, 2006 – BioTrove Inc. completed its latest fund raising by closing an additional $7 million in an oversubscribed round of venture capital funding, the Woburn, Mass.-based company reported today. The latest round brings the total amount raised since July 2005 to $15 million. Participating investors include Catalyst Health and Technology Partners, Echelon Ventures, Fletcher Spaght, and CB Health Ventures. The proceeds of this round will accelerate the commercialization of BioTrove’s genomics and pharmaceutical screening products.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.